Thank you @trq212@bcherny .. I was out of usage for Fable 5, then in the last hour I noticed I've got around 20-30% extra usage. Also the usage doesn't seem to go up as fast now (maybe low usage time?)
Not a full reset, but very thankful for this extra boost 🙏
@boldceo@JakeBuildThings@bcherny@claudeai Get opus to read the code base, identify or familiarise itself with the problems, fable to prepare the solution and opus to execute it.
@agingroy@Conception One of the fascinating things is the queen of naked mole rats, which this exceptional fertility that does not seem to decline with age, can we translate this to humans?
Digital creators are pivoting from luxury into AI and tech.
@xeniatchoumi at Cannes this week is one of the cleaner examples.. buried in this piece is her move into AI and digital entrepreneurship.
Who else is doing both lanes at once?
Xenia Tchoumi made a highly visible return to the 79th Cannes Film Festival this year as an official guest of Campari, continuing her long-standing positioning at the intersection of luxury, business, fashion, and modern digital entrepreneurship. bbntimes.com/society/xenia-…
Retatrutide. 28.3% weight loss. 70 pounds average. TRIUMPH-1 Phase 3, published yesterday.
Every headline says “triple agonist.” Almost none explain why the third receptor changes everything.
Ozempic and Mounjaro suppress appetite. That’s the GLP-1 and GIP part. Retatrutide adds a glucagon receptor. Glucagon doesn’t kill your hunger. It raises your resting energy expenditure. Your body burns more calories doing nothing. Two fronts: eating less AND burning more.
That’s why retatrutide posted 28.3% vs Mounjaro’s 22% vs Ozempic’s 15%. The gap is in the mechanism.
Phase 2 showed 24%. Phase 3 beat it. The high-BMI group lost 85 pounds over two years. Nearly half of all participants lost more than 30% of their body weight.
I ranked 9 drugs chasing Ozempic’s market a month ago. Retatrutide was #2. The full pipeline, with every mechanism and timeline, is below.
3 years ago, the obesity drug market was basically Ozempic.
Today, it's 9 drugs deep in late-stage. Here's what each one actually adds:
1. Foundayo: latest oral GLP-1. @US_FDA approved April 1, 2026. Injections become optional.
2. Retatrutide: 24% weight loss at 48 weeks
The thing I love most is going deep into many fields at once, then watching the connections appear between them. AI has just made that possible at a scale we never could have imagined
The strongest evidence-based tool for preventing Alzheimer’s and dementia may already be sitting in your shot record.
104 million people. 8 vaccines. All showing protection against brain diseases they were never designed to prevent.
Ranked by how much they lower Alzheimer’s and
I've built for myself very valuable helpers, e.g. CLIs or agent skills across several github accounts and orgs. They've been immensely helpful. I've built a CLI for managing X that's far above any other product or paid SaaS; there's been little traction. On the other hand, getting thousands of github stars then promoting your tool creates just so much more traction and adoption, it just doesn't make sense not to do it.
If I cared about people using what I built, getting more stars to support my application to work at Anthropic or raise money for a specific project, I would totally buy stars. I don't. Anyhow, on X, you can boost your posts. On github, you can't bost your repos. *wink* hidden opportunity *wink*
@CGrovesNLN If it's in context of power/strength/fatigue, albeit a different mechanism, I've had success with acetylcholin precursors (particularly alpha GPC)
@0xSero@badlogicgames Wasn’t Claude (and codex) scrambling and breaking the logs to protect themselves against distillation, from the earlier source code leak?
@martianwyrdlord For certain people with high risk variants of the ApoE gene, eating meat actually reduces the risks of dementia or co hmm cognitive decline. Higher protein intake is also strongly linked with less frailty. This is not promoting health, but political and social agendas.
@Ashwinreads Every once in a while, it's good to have something to reframe your perspective on money, and what it does to us and how it can help us. Nice light reading.
335 Followers 963 FollowingExecutive | AI + Crypto Enthusiast | Retro Gaming | Founder Mindset | Systems Thinker | Tech that Redefines how we Work + Play 🇦🇺
https://t.co/i7pxmLDfPo
5K Followers 3K FollowingAI maximalist. AGI/ASI before 2030. Creator of https://t.co/k60Hx3hHvj, which helps you craft AI assisted replies & (re)posts. In any niche, not just crypto. Free!
17 Followers 34 Following“Far more money has been lost by investors preparing for corrections, than has been lost in corrections themselves.” – Peter Lynch
39 Followers 325 FollowingAI researcher, working on real time multimodal applications in robots
Currently neuroscience and AI are what I indulge in. Preparing for Symbiosis
158K Followers 2K FollowingProfessor & NYT bestselling author of Lies I Taught in Medical School. Metabolic health, longevity & what your doctor gets wrong. Free weekly newsletter 👇
41K Followers 597 FollowingXenia Tchoumi official Swiss-Italian digital entrepreneur & public speaker based in London. #xenia #xeniatchoumitcheva #xeniatchoumi
3K Followers 6K FollowingI run @PopVaxIndia (https://t.co/dOKb3wZ7pr) – we develop mRNA vaccines and therapeutics using computational protein design. I write at https://t.co/reAXhjkSrU
25K Followers 26 FollowingWe advance the development of ASI and foster open source collaboration towards a smarter future.
Discord: https://t.co/BtsFsAUsvT
5K Followers 859 FollowingFounder/CEO of the only consumer longevity biotech @novoslabs https://t.co/SVNz05kwO7. https://t.co/bROmHZ8F6s tracks how I reduced my bio age 37% across algos
591K Followers 52K FollowingSan Francisco/Silicon Valley AI | Robots, holodecks, BCIs, analysis of new things | Ex-Microsoft, Rackspace, Fast Company | Wrote eight books about the future.
55K Followers 1K FollowingArmin's handler at https://t.co/B05ybKGkzx. Old man yelling at Claudes.
https://t.co/Q1wG57v1yc
https://t.co/mnOoWUr0TO
https://t.co/8i5vIRE0Wn
11 Followers 68 Following1 tech startup exit. 2 sci-fi AI novels (Artificial Wisdom, Infinite Wisdom) as Thomas R. Weaver. Now actively building again around agentic AI.
559K Followers 2K FollowingPolyagentmorous ClawFather. Came back from retirement to mess with AI and help a lobster take over the world.
@OpenClaw🦞 + @OpenAI
284 Followers 717 FollowingExclusive access to our award-winning documentary, a growing library of videos and articles, and direct engagement with top longevity experts.
84K Followers 2K FollowingBiohacking, supplements, nootropics, & peptides for peak performance. Followed by @HubermanLab. Tweets are not medical advice.
591 Followers 286 Following🔬Solving Aging using AI, @Forbes 30u30 2025, Research Faculty @yale; Director at @H_L_Clinic; Created SymphonyAge @TruDiagnostic, Principal @LongevityTechFund
625K Followers 1K FollowingProfessor researching why we age & how to reverse it. Author & host of Lifespan. Mission: Extend healthy life for all. Views are entirely his own. @joinlifespan
20K Followers 2K FollowingScientist planning to live forever (so far so good!), professor decoding the genome @unibirmingham, geek, entrepreneur, speaker, writer, keen footballer.
1.5M Followers 2 FollowingWe're an AI safety and research company that builds reliable, interpretable, and steerable AI systems. Talk to our AI assistant @claudeai on https://t.co/FhDI3KQh0n.